Abstract
A retrospective analysis was conducted of the cost of hypertension care at one internal medicine clinic, looking at the cost of office visits, laboratory tests, and medications. Cost of hypertension care was $947 the first year of treatment, $575 the second year, and $420 per year thereafter. Drug costs were the major determinant of cost of care, comprising 80% of the total cost of treatment after the first year of therapy.
This is a preview of subscription content, log in via an institution to check access.
References
Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study. JAMA. 1993;270:713–24.
Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97–104.
Wikstrand J, Warnold I, Olsson J, et al. Primary prevention with metoptolol in patients with hypertension. Mortality results from the MAPHY study. JAMA. 1988;259:1976–82.
Silagy CA, McNeil JJ, McGrath BP. Crossover comparison of atenolol. enalapril, hydrochlorothiazide and isradipinfor isolated systolic systemic hypertension. Am J Cardiol. 1992;70:1299–305.
Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six anti-hypertensive agents with placebo. N Engl J Med. 1993;328:914–21.
Report by the Management Committee. The Australian therapeutic trial in mild hypertension. Lancet. 1980;1:1261–6.
Helgeland A. Treatment of mild hypertension: a five year controlled drug trial—The Oslo Study. Am J Med. 1980;69:725–32.
Berglund G, Wilhelmsen L, Sannerstedt R, et al. Coronary heart disease after treatment of hypertension. Lancet. 1978;1:1–5.
Isles CG, Walker LM, Beevers GD, et al. Mortality in patients of the Glascow Blood Pressure Clinic. J Hypertens. 1986;4:141–56.
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. JAMA. 1979;242:2562–71.
Veterans Administration Cooperative Study Group on Anti-Hypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:116–22.
Veterans Administration Cooperative Study Group on Anti-Hypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA. 1970;213:1143–52.
SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–302.
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Fifth Report (JNC V). Arch Intern Med. 1993;153:54–183.
Stason WB. Opportunities to improve effectiveness of treatment for hypertension. Hypertension. 1991;18(suppl 1):161–6.
Hilleman DE. Mohiuddin SM, Lucas BD. et al. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension. Clin Ther. 1994;16:88–102.
Author information
Authors and Affiliations
Additional information
Received from the Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Rights and permissions
About this article
Cite this article
Odell, T.W., Gregory, M.C. Cost of hypertension treatment. J Gen Intern Med 10, 686–688 (1995). https://doi.org/10.1007/BF02602764
Issue Date:
DOI: https://doi.org/10.1007/BF02602764